🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 004225108
- Market Cap
- Large Cap
Business: ACADIA Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of innovative medicines that address unmet medical needs in neurological and related central nervous system disorders. ACADIA has developed and commercialized the first and only medicine approved for the treatment of hallucinations and delusions associated with Parkinson’s disease psychosis. ACADIA also has ongoing clinical development efforts in additional areas with significant unmet need, including dementia-related psychosis, schizophrenia, major depressive disorder, and Rett syndrome.
Company Contact
- CEO
- Catherine Owen Adams
- CFO
- Mark Schneyer
- Headquarters
- 12830 El Camino Real, Suite 400, San Diego, CA 92130
- Phone
- 704-252-5050
- Fax
- 858-558-2872
- Investor Relations
- Jessica Tieszen · 619-322-5969 · ir@acadia-pharm.com